Study on clinical and haematological profile of pancytopenia with special reference to bone marrow picture

Pradeep G. S.; Rohith C.

doi:10.18203/2349-3933.ijam20263718

Authors

Pradeep G. S. Department of Medicine, Rajiv Gandhi University of Health Sciences, Karnataka, India https://orcid.org/0009-0007-7693-8053
Rohith C. Department of Medicine, Rajiv Gandhi University of Health Sciences, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20263718

Keywords:

Pancytopenia, Megaloblastic anemia, Bone marrow examination, Vitamin B12 deficiency, Hypersplenism

Abstract

Background: Pancytopenia is a hematological condition characterized by the simultaneous reduction of red blood cells, white blood cells, and platelets. It represents a manifestation of various underlying disorders, ranging from nutritional deficiencies to hematological malignancies. Understanding the clinical and hematological profile, especially bone marrow morphology, is critical for diagnosis and management.

Methods: An observational study was conducted over 18 months at the Department of Medicine, K R Hospital, Mysuru, enrolling 35 adult patients diagnosed with pancytopenia. Detailed clinical history, physical examination, complete blood count, peripheral smear, serum vitamin B12 and folate levels, and bone marrow aspiration and biopsy were performed. Additional investigations were conducted as clinically indicated. Data were analyzed using appropriate statistical methods.

Results: The study population comprised 54.3% males and 45.7% females, with the majority aged between 31-40 years. The most common presenting symptom was easy fatigability (94.3%). Pallor was observed in all patients, with splenomegaly present in 51.4%. Hematological analysis revealed severe anemia, leukopenia, and thrombocytopenia. Peripheral smear predominantly showed macrocytic anemia (54.3%). Bone marrow examination revealed hypercellularity in 74.3% of cases. Megaloblastic anemia was the leading cause of pancytopenia (48.6%), followed by hypersplenism (14.3%) and aplastic anemia (11.4%).

Conclusions: Megaloblastic anemia due to vitamin B12 deficiency is the predominant cause of pancytopenia in this cohort, emphasizing the need for early nutritional assessment and intervention. Bone marrow evaluation remains a pivotal diagnostic tool, aiding in the identification of diverse etiologies and guiding appropriate management.

References

Vargas-Carretero CJ, Fernandez-Vargas OE, Ron-Magaña AL, Padilla-Ortega JA, Ron-Guerrero CS, Barrera-Chairez E. Etiology and clinico-hematological profile of pancytopenia: experience of a Mexican tertiary care center and review of the literature. Hematology. 2019;24(1):399-404.

Gupta G, Singh R, Kotasthane DS, Kotasthane VD. Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors – International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues. J Blood Med. 2010;1:171-82.

Patel GR, Prajapati GR. Spectrum of pancytopenia in adults attending a clinical hematology department: a four-year experience from a tertiary care center of Western India. Cureus. 2022;14(5):e24933.

Lucas D. Structural organization of the bone marrow and its role in hematopoiesis. Curr Opin Hematol. 2021;28(1):36-42.

Kachhawa GP, Kalla AR, Joshi YR, Singhvi A, Sharma T. Etiological spectrum of pancytopenia based on bone marrow examination. J Appl Biochem Lab Med. 2025;6(1):12-4.

Giudice V, Cardamone C, Triggiani M, Selleri C. Bone marrow failure syndromes, overlapping diseases with a common cytokine signature. Int J Mol Sci. 2021;22(2):705.

Sharma R, Nalepa G. Evaluation and management of chronic pancytopenia. Pediatr Rev. 2016;37(3):101-13.

Singh M, Singh V, Singh DP, Bohra GK, Misra AK. Hemorrhagic manifestation in different etiologies of pancytopenia: a prospective, cross-sectional study. J Family Med Prim Care. 2021;10(2):804-8.

Thachil J, Bates I. Approach to the diagnosis and classification of blood cell disorders. In: Bain BJ, Bates I, Laffan MA, editors. Dacie and Lewis Practical Haematology. 12th ed. Elsevier; 2017:497-510.

Zubair AB, Razzaq MT, Hashmi AW, Ali SMY, Israr MM, Sadiq SM, et al. Clinical characteristics and etiological spectrum of pancytopenia in pediatric age group: a cross-sectional outlook from a developing country. Cureus. 2022;14(8):e27842.

Parthasarathy V. Myeloid neoplasms in the guise of nutritional deficiency. Case Rep Hematol. 2012;2012:826939.

Kumar R, Kalra SP, Kumar H, Anand AC, Madan H. Pancytopenia--a six year study. J Assoc Physicians India. 2001;49:1078-81.

Tilak V, Jain R. Pancytopenia--a clinico-hematologic analysis of 77 cases. Indian J Pathol Microbiol. 1999;42(4):399-404.

Jha A, Sayami G, Adhikari RC, Panta AD, Jha R. Bone marrow examination in cases of pancytopenia. JNMA J Nepal Med Assoc. 2008;47(169):12-7.

Jain A, Garg R, Kaur R, Nibhoria S, Chawla SPS, Kaur S. Clinico-hematological profile of pancytopenic adult patients in a tertiary care teaching hospital. Tzu Chi Med J. 2022;34(1):95-101.

Gayathri BN, Rao KS. Pancytopenia: a clinico hematological study. J Lab Physicians. 2011;3(1):15-20.

Khunger JM, Arulselvi S, Sharma U, Ranga S, Talib VH. Pancytopenia--a clinico haematological study of 200 cases. Indian J Pathol Microbiol. 2002;45(3):375-9.

Trivette ET, Hoedebecke K, Berry-Cabán CS, Jacobs BR. Megaloblastic hematopoiesis in a 20 year old pregnant female. Am J Case Rep. 2013;14:10-2.

Kumar R, Kalra SP, Kumar H, Anand AC, Madan H. Pancytopenia--a six year study. J Assoc Physicians India. 2001;49:1078-81.

Imbert M, Scoazec JY, Mary JY, Jouzult H, Rochant H, Sultan C. Adult patients presenting with pancytopenia: a reappraisal of underlying pathology and diagnostic procedures in 213 cases. Hematol Pathol. 1989;3(4):159-67.

Weinzierl E, Arber DA. New-onset pancytopenia: a diagnostic approach--reply. Hum Pathol. 2014;45(7):1552-3.